Home › Funds › Mystic Asset Management, Inc. › ZVRA

Mystic Asset Management, Inc. position in ZVRA

ZEVRA THERAPEUTICS INC · Health Care

Mystic Asset Management, Inc. reported holding 355,380 shares of ZVRA (ZEVRA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$3.9M, representing 0.86% of its reported portfolio and ranking #30 among its reported holdings. Mystic Asset Management, Inc. has disclosed ZVRA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)355.38K sh
Reported value held$3.90M
Portfolio Weight0.86%
First reportedQ3 2023
Last changeAdd
Updated2026-10-15

Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR

How Mystic Asset Management, Inc.'s ZVRA position evolved

Mystic Asset Management, Inc. first disclosed a stake in ZVRA in Q3 2023 at 203,283 shares (US$980K). The position peaked in Q2 2026 at 352,110 shares, worth US$5.0M. Across 13 filings, Mystic Asset Management, Inc. increased the stake 9 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 355,380 shares valued at US$3.9M — an increase of 3,270 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 203.28K $979.82K New
Q4 2023 230.78K $1.51M Add
Q1 2024 266.30K $1.54M Add
Q2 2024 297.95K $1.46M Add
Q3 2024 307.45K $2.13M Add
Q4 2024 313.35K $2.61M Add
Q1 2025 338.90K $2.54M Add
Q2 2025 346.65K $3.05M Add
Q3 2025 346.65K $3.30M Hold
Q4 2025 346.53K $3.10M Hold
Q1 2026 361.28K $3.37M Add
Q2 2026 352.11K $5.05M Reduce
Q3 2026 355.38K $3.90M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ZVRA and 13F data

ZVRA (ZEVRA THERAPEUTICS INC) is a Health Care company. 56 other funds we track also report a position in ZVRA — the largest reported positions include Nantahala Capital Management, LLC (US$25.8M), 683 Capital Management, LLC (US$12.3M), KINGDON CAPITAL MANAGEMENT, L.L.C. (US$11.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ZVRA

All ZVRA fund holders →

FAQ

How long has Mystic Asset Management, Inc. held ZVRA?

Mystic Asset Management, Inc. has disclosed ZVRA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Mystic Asset Management, Inc.'s current position in ZVRA?

As of Q3 2026, Mystic Asset Management, Inc. holds 355.38K shares of ZVRA (ZEVRA THERAPEUTICS INC), valued at $3.90M, representing 0.86% of its reported portfolio and ranking #30.

Has Mystic Asset Management, Inc. been buying or selling ZVRA?

In the latest 13F filing (Q3 2026), Mystic Asset Management, Inc. increased its position in ZVRA. The position peaked in Q2 2026 at 352.11K shares.

Which other funds hold ZVRA?

Other major institutional holders of ZVRA include Nantahala Capital Management, LLC, 683 Capital Management, LLC, KINGDON CAPITAL MANAGEMENT, L.L.C., among 56 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.